Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
出版年份 2017 全文链接
标题
Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 18, Issue 16, Pages 1679-1689
出版商
Informa UK Limited
发表日期
2017-10-25
DOI
10.1080/14656566.2017.1391217
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells
- (2018) Marije J. Veenstra et al. Oncotarget
- Antitumour activity of somatostatin analogues in sporadic, progressive, metastatic pulmonary carcinoids
- (2017) Ivana Sullivan et al. EUROPEAN JOURNAL OF CANCER
- High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study
- (2017) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin Receptor Antagonists for Imaging and Therapy
- (2017) Melpomeni Fani et al. JOURNAL OF NUCLEAR MEDICINE
- Biodistribution, Pharmacokinetics, and Dosimetry of 177 Lu-, 90 Y-, and 111 In-Labeled Somatostatin Receptor Antagonist OPS201 in Comparison to the Agonist 177 Lu-DOTATATE: The Mass Effect
- (2017) Guillaume P. Nicolas et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antisecretory Effects of Chimeric Somatostatin/Dopamine Receptor Ligands on Gastroenteropancreatic Neuroendocrine Tumors
- (2017) Anne Couvelard et al. PANCREAS
- Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
- (2017) James Yao et al. OncoTargets and Therapy
- Everolimus treatment for neuroendocrine tumors: latest results and clinical potential
- (2017) Sara Pusceddu et al. Therapeutic Advances in Medical Oncology
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
- (2017) Arvind Dasari et al. JAMA Oncology
- Neuroendocrine Tumors
- (2017) Journal of the National Comprehensive Cancer Network
- Peptide receptor radionuclide therapy of neuroendocrine tumours
- (2016) Tessa Brabander et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Anti-tumour effects of lanreotide for pancreatic and intestinal neuroendocrine tumours: the CLARINET open-label extension study
- (2016) Martyn E Caplin et al. ENDOCRINE-RELATED CANCER
- Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1–Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression
- (2016) Gerard V. Walls et al. ENDOCRINOLOGY
- Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors
- (2016) Omid Fotouhi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Upregulation of Key Molecules for Targeted Imaging and Therapy
- (2016) V. F. Taelman et al. JOURNAL OF NUCLEAR MEDICINE
- Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions
- (2016) C. M. Deroose et al. JOURNAL OF NUCLEAR MEDICINE
- Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells
- (2016) Roxanne C.S. van Adrichem et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
- (2016) B. Niederle et al. NEUROENDOCRINOLOGY
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival
- (2016) Anja Rinke et al. NEUROENDOCRINOLOGY
- Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer
- (2016) Lisa Bodei et al. SEMINARS IN NUCLEAR MEDICINE
- The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
- (2016) Seung Tae Kim et al. Journal of Cancer
- 177Lu-OPS201 targeting somatostatin receptors: in vivo biodistribution and dosimetry in a pig model
- (2016) Seval Beykan et al. EJNMMI Research
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
- (2015) M. E. Caplin et al. ANNALS OF ONCOLOGY
- The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis
- (2015) Sebastian Richards-Taylor et al. JOURNAL OF CLINICAL PATHOLOGY
- Comparison of the Therapeutic Response to Treatment with a 177Lu-Labeled Somatostatin Receptor Agonist and Antagonist in Preclinical Models
- (2015) S. U. Dalm et al. JOURNAL OF NUCLEAR MEDICINE
- Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition
- (2015) Mauro Cives et al. NEUROENDOCRINOLOGY
- Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues
- (2015) Edward Wolin et al. Drug Design Development and Therapy
- Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?
- (2015) Kalliopi Domvri et al. Journal of Cancer
- Impact of long-acting octreotide in patients with early-stage MEN1-related duodeno-pancreatic neuroendocrine tumours
- (2014) V. Ramundo et al. CLINICAL ENDOCRINOLOGY
- Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures
- (2014) A. Mohamed et al. ENDOCRINE-RELATED CANCER
- Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors
- (2014) Andrea Giustina et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Parathyroid Hormone-Related Peptide (PTHrP) Secretion by Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Clinical Features, Diagnosis, Management, and Follow-Up
- (2014) Kimberly Kamp et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparison of Somatostatin Receptor Agonist and Antagonist for Peptide Receptor Radionuclide Therapy: A Pilot Study
- (2014) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
- (2014) Martyn E. Caplin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study
- (2012) Larry K Kvols et al. ENDOCRINE-RELATED CANCER
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy
- (2011) Gherardo Mazziotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
- (2011) D. Wild et al. JOURNAL OF NUCLEAR MEDICINE
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
- (2011) Marianne E Pavel et al. LANCET
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial
- (2009) Andrea Giustina et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan)
- (2009) N. Hillman et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
- (2009) Gherardo Mazziotti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial
- (2009) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
- (2008) Mark Kidd et al. CANCER
- Differential Effects of Octreotide and Pasireotide on Somatostatin Receptor Internalization and Traffickingin Vitro
- (2008) Sarah Lesche et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
- (2008) James C. Yao et al. JOURNAL OF CLINICAL ONCOLOGY
- Cell Growth Inhibition and Functioning of Human Somatostatin Receptor Type 2 Are Modulated by Receptor Heterodimerization
- (2008) Michael Grant et al. MOLECULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now